The Chicago Entrepreneur

Dow Jones Newswires: AstraZeneca’s Forxiga gets EU approval recommendation for symptomatic chronic heart failure

The recommendation covers heart failure with reduced ejection fraction–a measure of the amount of blood the heart’s left ventricle pumps with each heartbeat.

Previous post Dow Jones Newswires: AstraZeneca’s Imfinzi plus Imjudo recommended for approval in the EU
Next post It is important to regulate crypto issuers and intermediaries, says Gensler